Analysts Offer Insights on Healthcare Companies: Sintx Technologies (SINT) and Cyclo Therapeutics (CYTH)
April 05 2022 - 07:25AM
TipRanks
There's a lot to be optimistic about in the Healthcare sector as 2
analysts just weighed in on Sintx Technologies (SINT – Research
Report) and Cyclo Therapeutics (CYTH – Research Report) with
bullish sentiments. Sintx Technologies (SINT) In a report released
yesterday, Tate Sullivan from Maxim Group maintained a Buy rating
on Sintx Technologies, with a price target of $1.75. The company's
shares closed last Monday at $0.62, close to its 52-week low of
$0.40. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sintx-technologies-sint-and-cyclo-therapeutics-cyth?utm_source=advfn.com&utm_medium=referral
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Dec 2022 to Jan 2023
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Jan 2022 to Jan 2023